Dexamethasone for Post-cesarean Delivery Pain

Dexamethasone as an Analgesic Adjunct for Post-cesarean Delivery Pain Relief

The purpose of this study is to compare post-cesarean section consumption of pain medication between two groups of patients undergoing scheduled cesarean section at term gestation who receive a single-dose of intraoperative steroid (dexamethasone 8 milligrams) versus placebo at 24 hours after surgery. The hypothesis is that a single perioperative dose of dexamethasone 8 mg will significantly reduce postoperative opioid consumption at 24 h in women having cesarean delivery under spinal anesthesia.

Study Overview

• Status: Completed
• Conditions: Pain, Postoperative; Postoperative Nausea and Vomiting
• Intervention / Treatment: Drug: Dexamethasone; Drug: Placebo

Detailed Description

Steroids have been used to reduce inflammation and tissue damage in a variety of conditions, have potent immunomodulatory effects, and are a mainstay in the treatment of acute allograft rejection. Dexamethasone has been shown to be a safe and effective anti-emetic therapy for patients undergoing cesarean section surgery with spinal anesthesia containing morphine.

However, recent evidence suggests that dexamethasone may also play a role in reducing post-operative pain and opioid consumption. Early studies in patients undergoing dental procedures showed that glucocorticoids were effective in reducing postoperative pain and edema. Multiple recent studies have also investigated the potential analgesic benefit of a single perioperative dose of dexamethasone, but the results have been inconsistent. The effect of single-dose, intraoperative, intravenous dexamethasone therapy on post-operative pain and opioid consumption has not yet been studied in patients undergoing cesarean section.

Pain is a significant source of morbidity for many women following cesarean section, and has serious consequences beyond the immediate post-operative period. Patients with poorly-controlled pain may have difficulty with ambulation that can lead to atelectasis, pneumonia, and venous thromboembolism.

Poor maternal pain control may also affect the infant by interfering with bonding and breastfeeding. Reduction of post-operative opioid consumption is desirable because it may also reduce the incidence of opioid-induced side effects such as sedation, constipation, nausea, vomiting and pruritus. Some evidence suggests that the severity of post-operative pain following cesarean section may predict progression to chronic pain, and postpartum depression.

Although 10 to 18% of women who undergo cesarean section will experience chronic pain following surgery, it is difficult to predict those patients who will experience this complication. Recent investigations have shown that patient responses to standardized painful stimuli prior to surgery help predict severity of post-operative pain and possibly progression to chronic pain. This type of information could potentially help to tailor the clinical management of patients at risk for severe and/or chronic post-operative pain to improve outcomes for these patients. Landau and colleagues have described a simple and minimally-invasive method of assessing response to noxious stimuli using a von-Frey filament to obtain a mechanical temporal summation score.

• Study Type: Interventional
• Enrollment (Actual): 53
• Phase: Phase 4

Contacts and Locations

Study Locations

• United States
  • North Carolina
    • Durham, North Carolina, United States, 27705
      • Duke University Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• American Society of Anesthesiology (ASA) class 1, 2 and 3
• Gestational age > 37 weeks
• scheduled for elective cesarean delivery
• spinal or combined spinal epidural anesthesia
• 18 years or older
• speak English

Exclusion Criteria:

• BMI > 45 kg/m2
• Diabetes Mellitus (Type 1, 2 and gestational)
• mild or severe preeclampsia
• history of intravenous drug or opioid abuse
• previous history of chronic pain syndrome
• history of opioid use in the past week
• receipt of an antiemetic within 24 h prior to surgery
• Non-English speaking

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Quadruple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Dexamethasone; Dexamethasone 8 mg IV given intraoperatively as a one-time dose.	Drug: Dexamethasone; Dexamethasone 8 mg IV (as a one time dose)
Placebo Comparator: Placebo; Sodium chloride 0.9% (5 ml) given IV intraoperatively as a one time dose.	Drug: Placebo; Sodium Chloride 0.9% -5 ml; Other Names: Sodium Chloride 0.9%

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Morphine Consumption at 24 Hours Post-op	The primary outcome will be the cumulative morphine consumption at 24 h in the two study groups. All postoperative opioids were converted to IV morphine equivalents using the following conversion factors: 100 micrograms IV = 10 mg IV morphine, 20 mg oxycodone po = 10 mg IV Morphine	24 hours from admission to Postanesthesia care unit (PACU)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain Scores Between the Groups at 2 Hours.	Pain scores were measured using a numeric rating scale with a range from 0 to 10, with 0 meaning no pain and 10 indicating the most severe pain.	2 hours from admission to postanesthesia care unit (PACU)
Time to Administration of First Rescue Analgesic Request Between the Groups.	Time in minutes from admission to PACU to the first request by the patient for oral oxycodone (analgesia) administration for pain	PACU admission to discharge from PACU an average of 2 hours
Cumulative Opioid Consumption at 48 Hours Between the Groups	The secondary outcome was the cumulative morphine consumption at 48 h in the two study groups. All postoperative opioids were converted to IV morphine equivalents using the following conversion factors: 100 micrograms IV = 10 mg IV morphine, 20 mg oxycodone po = 10 mg IV Morphine	Admission to PACU through 48 hours
Pain Scores Between the Groups at 24 Hours.	Pain scores were measured using a numeric rating scale with a range from 0 to 10, with 0 meaning no pain and 10 indicating the most severe pain.	24 hours from PACU admission
Pain Scores Between the Groups at 48 Hours.	Pain scores were measured using a numeric rating scale with a range from 0 to 10, with 0 meaning no pain and 10 indicating the most severe pain.	48 hours from PACU Admission
Cumulative Opioid Consumption at 24 Hours Between MTS Groups	Mechanical temporal summation (MTS) was assessed using A 180 g Von Frey Filament was applied to the volar aspect of the dominant forearm, and subjects were asked to rate pain scores (NRS 0-100, 0 = no pain and 100= worst pain possible) after the 1st and 11th tap. A difference < 1 was recorded as MTS negative, and a difference > or = 1 was recorded as MTS positive.	24 hours from admission to Postanesthesia care unit (PACU)
Incidence of Chronic Persistent Pain at 8 Weeks	Patients answered a questionnaire at 8 weeks to determine whether they still had persistent surgical site pain 8 weeks following surgery	8 weeks from the day of surgery
Incidence of Chronic Persistent Pain at 6 Months	Patients answered a questionnaire at 6 months to determine whether they still had persistent surgical site pain 6 months following surgery	6 months from the day of surgery
Pain Scores Between MTS Groups	Mechanical temporal summation (MTS) was assessed using A 180 g Von Frey Filament was applied to the volar aspect of the dominant forearm, and subjects were asked to rate pain scores (NRS 0-100, 0=no pain and 100=worst pain possible) after the 1st and 11th tap. A difference < 1 was recorded as MTS negative, and a difference > or = 1 was recorded as MTS positive.	24 hours after PACU admission
Incidence of Intraoperative Nausea and Vomiting (IONV) and Need for Rescue Antiemetics.	Incidence of intraoperative nausea and vomiting and need for rescue antiemetics were recorded during surgery. Patient who reported a nausea score on a 11 point NRS where 0=no nausea and 10 = the worse nausea possible. Patients who retched or vomited were reported to have vomited. Patients receiving any antiemetic during surgery were recorded as those requesting ( needing) rescue antiemetic.	From spinal anesthesia placement to end of surgery, approximately 70 minutes
Incidence of Intraoperative Pruritus	pruritus was defined as patients reporting a pruritus score of greater than o on a numerical rating scale with o=no pruritus and 10= worst pruritus	From spinal anesthesia placement to end of surgery, approximately 70 minutes
Incidence of Postoperative Pruritus	Incidence of postoperative pruritus was calculated based on their postoperative pruritus scores measured at 2 hours, 24 hours and 48 hours. Median of the scores recorded at three time points was calculated. If median score >0 then patient experienced postoperative pruritus.	48 hours from admission to PACU
Need for Intraoperative Analgesic Supplementation	Need for intraoperative analgesic supplementation was determined by patients who required intraoperative analgesics for pain	From spinal anesthesia placement to end of surgery, approximately 70 minutes
Incidence of Post-operative Nausea and Vomiting (PONV) and Need for Rescue Antiemetics	Patients who had experienced Postoperative nausea either reported postoperative nausea scores at 2, 24 and 48 hours from >0, reported an episode of vomiting or received an antiemetic were recorded as experiencing PONV. Patients who received at least one rescue antiemetic postoperatively were recorded as requiring a rescue antiemetic	2, 24 and 48 hours from PACU admission
Incidence of Wound Complications	Patients were assessed for signs of surgical wound inspection by the obstetric team following surgery	24 hours from PACU admission
Blood Pressure Measurements Obtained by the Standard of Care Non-invasive Blood Pressure Monitor Compared With the Continuous Noninvasive Arterial Pressure (CNAP)		Intraoperatively

Collaborators and Investigators

• Sponsor: Duke University
• Investigators: Principal Investigator: Terrence Allen, MD, Duke University

Publications and helpful links

General Publications

• Griffiths JD, Gyte GM, Popham PA, Williams K, Paranjothy S, Broughton HK, Brown HC, Thomas J. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. Cochrane Database Syst Rev. 2021 May 18;5(5):CD007579. doi: 10.1002/14651858.CD007579.pub3.

Study record dates

Study Major Dates

• Study Start: December 1, 2012
• Primary Completion (Actual): May 27, 2016
• Study Completion (Actual): September 21, 2016

Study Registration Dates

• First Submitted: March 13, 2013
• First Submitted That Met QC Criteria: March 13, 2013
• First Posted (Estimate): March 15, 2013

Study Record Updates

• Last Update Posted (Actual): July 25, 2017
• Last Update Submitted That Met QC Criteria: June 26, 2017
• Last Verified: June 1, 2017

More Information

Terms related to this study

• Keywords: morphine; Postoperative Nausea and Vomiting; Dexamethasone; Anesthesia; Cesarean Section; Pain, Postoperative; Injections, Spinal
• Additional Relevant MeSH Terms: Pathologic Processes; Postoperative Complications; Pain; Neurologic Manifestations; Signs and Symptoms, Digestive; Pain, Postoperative; Nausea; Vomiting; Postoperative Nausea and Vomiting; Physiological Effects of Drugs; Autonomic Agents; Peripheral Nervous System Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antiemetics; Gastrointestinal Agents; Glucocorticoids; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Antineoplastic Agents, Hormonal; Dexamethasone
• Other Study ID Numbers: Pro00041334